Categories · Health/Science
· Cessation
· Tobacco Control
· Business (General)
Organizations · Dhhs
|
Nymox -NASDAQ:NYMX- NicAlert Product Valuable Tool for Smoking Cessation Programs Jump to full article: Business Wire, 2003-09-18 Author: Source: Nymox Pharmaceutical Corporation
Intro: A new report from the U.S. Department of Health and Human Services (HHS) targets tobacco use - the single most preventable cause of death in the U.S. - as a key part of business strategy to improve productivity and reduce healthcare costs. According to the report entitled "Prevention Makes Common `Cents'" covering treatments to help employees quit smoking offers substantial savings for employers in the costs of treating smoking-related illness. Earlier, in July 2003, the CEOs of several dozen major corporations announced their agreement to extend coverage for smoking cessation programs to 8 million employees and 17 million dependents as part of a comprehensive cancer screening and prevention program.
Nymox's NicAlert(TM) product is a valuable and cost-effective aid for smoking cessation programs. NicAlert can accurately and quickly determine a person's level of tobacco use and exposure on-site without the need for instruments or special training. NicAlert received clearance from the U.S. FDA in October 2002.
Jump to full article » |